The Latest Cardiac and Vascular News
Newly published research shows that Cardiologs’ deep learning model can predict the short-term risk of atrial fibrillation (AFib) based on 24-hour Holter recordings that show normal sinus rhythm. PARIS and BOSTON, June 21, 2022 /PRNewswire/ — Cardiologs, a global leader in artificial intelligence (AI) cardiology diagnostics, announced today that its latest study, “Short-term prediction of atrial […]
AUSTIN, Texas, June 15, 2022 /PRNewswire/ — On June 2 and 3, 2022, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center hosted its sixth international symposium on complex arrhythmias, EPLive 2022. This year’s event had more than 1,250 people register, a record number, with more than 150 who attended in person. […]
TAMPA, Fla., June 9, 2022 /PRNewswire/ — Smart Meter, continues to lead the way in the remote patient monitoring (RPM) sector because of its superior cellular-enabled devices and robust data that facilitate better care management. During Men’s Health Month, Smart Meter wants to remind patients and providers that high blood pressure and obesity, […]
The US Food and Drug Administration has registered Qpatch, an ECG wearable unit developed by experts from Medicalgorithmics. The FDA approval allows use of ECG readings from Qpatch in the United States. WARSAW, Poland, June 9, 2022 /PRNewswire/ — Qpatch is a state-of-the-art wearable device for measuring individual ECG signal to obtain accurate […]
CRACOW, Poland, June 8, 2022 /PRNewswire/ — The AI-based system developed by Cardiomatics streamlines the work of cardiologists by supporting ECG interpretation. Now, the doctors at PZU Zdrowie (a Polish healthcare provider associated with PZU Group – one of the top insurance companies in East-Central Europe) will be able to take advantage of its […]
Trial will evaluate the safety and effectiveness of AtriCure’s Isolator® Synergy™ Clamp in conjunction with endocardial catheter ablation for the treatment of Inappropriate Sinus Tachycardia MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain […]
CAMBRIDGE, Mass., June 06, 2022 (GLOBE NEWSWIRE) — ALLM announced today that it has been named a compatible vendor within the American Heart Association Get With The Guidelines® program. This premier AHA (American Heart Association) program assists hospitals in measuring and improving cardiovascular disease and stroke care through research-based methods, […]
— Submission seeks approval for landiolol for the short-term reduction of ventricular rate in patients with supraventricular tachycardia, including atrial fibrillation and atrial flutter — — Expected approval mid-year 2023, if accepted by FDA for filing, based on feedback from U.S. Food and Drug Administration (“FDA”) provided during AOP Health’s […]
Commercial pipeline to include 30 advanced leads at Medical Centers of Excellence Company’s development and operational infrastructure will be on track to support anticipated sales growth following commercial rollout on July 1, 2022 BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company advancing electrophysiology workflow by delivering greater intracardiac signal fidelity […]
The Company’s flagship technology to be featured during a two-day educational conference that draws the world’s top cardiac electrophysiology experts Westport, CT, May 25, 2022 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company advancing electrophysiology workflow by delivering greater intracardiac signal fidelity […]
